Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic

Singapore Med J. 2020 Dec;61(12):619-623. doi: 10.11622/smedj.2020069. Epub 2020 Apr 29.

Abstract

In this paper, we aim to provide professional guidance to clinicians who are managing patients with chronic liver disease during the current coronavirus disease 2019 (COVID-19) pandemic in Singapore. We reviewed and summarised the available relevant published data on liver disease in COVID-19 and the advisory statements that were issued by major professional bodies, such as the American Association for the Study of Liver Diseases and European Association for the Study of the Liver, contextualising the recommendations to our local situation.

Keywords: COVID-19; SARS-CoV-2; hepatology.

Publication types

  • Practice Guideline

MeSH terms

  • COVID-19 / complications*
  • COVID-19 / epidemiology
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / therapy
  • Chronic Disease
  • Hepatitis B, Chronic / complications
  • Hepatitis B, Chronic / therapy
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / therapy
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / therapy
  • Liver Diseases / etiology
  • Liver Diseases / therapy*
  • Liver Neoplasms / complications
  • Liver Neoplasms / therapy
  • Liver Transplantation
  • Singapore / epidemiology